NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CANC

Tema Oncology ETF

Jun 20 • 04:00PM ET

24.38

Dollar change -0.70
Percentage change -2.79	%

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	-10.40%	Shs Outstand		Perf Week	-6.80%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	Total Holdings	51	Perf Month	1.18%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	AUM	69.59M	Perf Quarter	-3.08%
Index	-	Average Maturity		Tags	-	Return% 10Y		NAV%		Perf Half Y	-3.96%
Index Weighting		Commodity Type		Tags	-	Return% SI		NAV/sh		Perf YTD	0.30%
Active/Passive		Quant Type		Tags	-	Flows% 1M	3.95%	52W Range	20.10 - 29.85	Perf Year	-9.64%
Dividend TTM	0.50 (2.05%)	ESG Type		Tags	-	Flows% 3M	6.92%	52W High	-18.34%	Beta	1.00
Dividend Ex-Date	Dec 11, 2024	Dividend Type		Sector/Theme		Flows% YTD	48.10%	52W Low	21.32%	ATR (14)	0.62
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		RSI (14)	46.83	Volatility	1.79% 1.91%
Expense	0.75%	Growth/Value		SMA20	-1.85%	Flows% 3Y		Rel Volume	0.98	Prev Close	25.08
Inverse/Leveraged		Market Cap		SMA50	1.15%	Flows% 5Y		Avg Volume	8.79K	Price	24.38
IPO	Aug 16, 2023	Option/Short	No / Yes	SMA200	-5.25%	Trades		Volume	8,588	Change	-2.79%

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience